Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery

Yoichi Hamai,Jun Hihara,Manabu Emi,Takaoki Furukawa,Yuji Murakami,Ikuno Nishibuchi,Yuta Ibuki,Ichiko Yamakita,Tomoaki Kurokawa,Yasushi Nagata,Morihito Okada

Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery

2018

Yoichi Hamai
Jun Hihara
Manabu Emi
Takaoki Furukawa
Yuji Murakami
Ikuno Nishibuchi
Yuta Ibuki
Ichiko Yamakita
Tomoaki Kurokawa
Yasushi Nagata
Morihito Okada

Background Intensive trimodality therapy is needed for locally advanced esophageal squamous cell carcinoma (ESCC). However, some patients develop recurrence and die of cancer even after trimodality therapy.

Keywords:

Surgery
Carcinoma
Cancer
General surgery
Chemoradiotherapy
Medicine
esophageal squamous cell carcinoma
Abdominal surgery
Cardiothoracic surgery
Vascular surgery
neoadjuvant chemoradiotherapy
Cardiac surgery
locally advanced

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations